Biofrontera Inc. (BFRIW) Total liabilities 2020–2025
Biofrontera Inc. (BFRIW) total liabilities at each fiscal year-end, per SEC filings.
$18.1MFY2025 · since FY2020: $18.3M → $18.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.1M | +2.4% |
| FY2024 | $17.7M | -23.6% |
| FY2023 | $23.1M | -14.3% |
| FY2022 | $27.0M | -35.5% |
| FY2021 | $41.9M | +128.7% |
| FY2020 | $18.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BFRIW financial trends
BFRIW RevenueBFRIW Net incomeBFRIW Net marginBFRIW Gross profitBFRIW Gross marginBFRIW Operating incomeBFRIW Operating marginBFRIW Operating cash flowBFRIW Free cash flowBFRIW Capital expendituresBFRIW Return on equityBFRIW Stock buybacksBFRIW Dividends paidBFRIW Total assetsBFRIW Shareholders’ equityBFRIW overview →